Clinical Trial Update: Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This document reports a completed Phase I/II clinical trial evaluating autologous bone marrow-derived mesenchymal stem cells for relapsing-remitting multiple sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS) | Phase 1, Phase 2 | Status: COMPLETED